1. Ajani, J.A., Baker, F.L., Spitzer, G., Kelly, A., Brock, W., Tomasovic, B., Singletary S.E., McMurtrey, M. and Plager, C. (1987). Comparison between clinical response and in vitro drug sensitivity of primary human tumors in the adhesive tumor cell culture system. J Clin. Oncol. 5, 1912–1921.
2. Anai, H., Maehara, Y., Kusumoto, H. and Sugimachi, K. (1987). Comparison of the chemosensitivity of human neoplastic tissues between succinate dehydrogenase inhibition test and ATP assay [LETTER]. Clin Chim. Acta 166, 107–119.
3. Arai, T. and Suzuki, M. (1956). A rapid agar dilution technique for the estimation of antitumor cell activity. J. Antibiot. (Tokyo) 9, 169.
4. Ardarlan, B., MacDonald, J., Cooney, D. et al. (1981). The potential for clinical applications of in vitro assays for predicting 5-FU sensitivity in man. Cancer Treat. Rep. 65, 57–61.
5. Arenzana-Seisdedos, F., Mogensen, S.C., Vuillier, F., Fiers, W. and Virelizier, J.-L. (1988). Autocrine secretion of tumor necrosis factor under the influence of interferon-gamma amplifies HLA-DR gene induction in human monocytes. Proc. Natl. Acad. Sci. USA 85, 6087–6091.